Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Anagrelide | Reduction of elevated platelet counts | Red | n/a | Hertfordshire and West Essex ICB |
| Avatrombopag | Primary chronic immune thrombocytopenia | Red | Decision document | Hertfordshire and West Essex ICB |
| Avatrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dalteparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Deep Vein Thrombosis (DVT) | n/a | Clinical pathways | East and North Hertfordshire | |
| Deferasirox | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Deferiprone | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Desferrioxamine | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Eltrombopag | Thrombocytopenia related to hepatitis C | Red | Decision document | Hertfordshire and West Essex ICB |
| Eltrombopag | Aplastic anaemia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Eltrombopag ITP | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Enoxaparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Epoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Epoietin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Erythropoiesis stimulating agents | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Ferric maltol | Iron deficiency | Double Red | n/a | Hertfordshire and West Essex ICB |
| Filgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Fondaparinux | Thrombosis | Red | n/a | Hertfordshire and West Essex ICB |
| Fostamatinib | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Sickle Cell Disease | Red | n/a | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Myeloproliferative neoplasms | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Iron chelators | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Iron dextran | Iron deficiency | Red | n/a | Hertfordshire and West Essex ICB |
| Lenograstim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Low molecular weight heparin (LMWH) | Anticoagulation | Red | Decision document | Hertfordshire and West Essex ICB |
| Lusutrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Pegfilgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Myeloproliferative neoplasms (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Rituximab | Autoimmune haemolytic anaemia (AIHA) | Red | Decision document | Hertfordshire and West Essex ICB |
| Romiplostim | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Roxadustat | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Ruxolitinib | Polycythaemia vera (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |